Thomas H Smith Selected Research

respirantin

7/2007

Antineoplastic agents. 561. Total synthesis of respirantin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thomas H Smith Research Topics

Disease

6	Neoplasms (Cancer) 01/2021 - 07/2007
4	Inflammation (Inflammations) 01/2021 - 01/2013
1	Melanoma (Melanoma, Malignant) 01/2021
1	Adenocarcinoma of Lung 11/2020
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020
1	Thrombosis (Thrombus) 01/2017
1	Non-alcoholic Fatty Liver Disease 09/2013
1	Hypertension (High Blood Pressure) 09/2013
1	Obesity 09/2013
1	Lymphoid Leukemia 07/2007

Drug/Important Bio-Agent (IBA)

2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2017 - 01/2013
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	InterferonsIBA 01/2021
1	Programmed Cell Death 1 ReceptorIBA 01/2021
1	IpilimumabIBA 01/2021
1	NivolumabIBA 11/2020
1	Biological ProductsIBA 03/2015
1	dolastatin 16IBA 03/2015
1	ChemokinesIBA 01/2014
1	SteroidsIBA 09/2013
1	Peptide Hydrolases (Proteases)FDA Link 01/2013
1	Proteinase-Activated ReceptorsIBA 01/2013
1	Growth InhibitorsIBA 07/2007
1	Anti-Bacterial Agents (Antibiotics)IBA 07/2007
1	antimycinIBA 07/2007
1	DepsipeptidesIBA 07/2007
1	respirantinIBA 07/2007

Therapy/Procedure

2	Immunotherapy 01/2021 - 01/2020
1	Neoadjuvant Therapy 01/2021
1	Drug Therapy (Chemotherapy) 01/2020
1	Therapeutics 09/2013